Literature DB >> 11685157

Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?

J Spertus.   

Abstract

Mesh：

Year:  2001        PMID： 11685157     DOI： 10.1067/mhj.2001.119135

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

1.  Assessing patients' improvement in clinical trials.

Authors:  John Spertus
Journal:  BMJ       Date:  2008-05-21

2.  Neuroticism personality trait is associated with Quality of Life in patients with Chronic Heart Failure.

Authors:  Lampros Samartzis; Stavros Dimopoulos; Christos Manetos; Varvara Agapitou; Athanasios Tasoulis; Eleni Tseliou; Iraklis Pozios; Elisavet Kaldara; John Terrovitis; Serafim Nanas
Journal:  World J Cardiol       Date:  2014-10-26

3.  Gender differences in pre-event health status of young patients with acute myocardial infarction: A VIRGO study analysis.

Authors:  Rachel P Dreyer; Kim G Smolderen; Kelly M Strait; John F Beltrame; Judith H Lichtman; Nancy P Lorenze; Gail D'Onofrio; Héctor Bueno; Harlan M Krumholz; John A Spertus
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2015-02-13

4.  Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy.

Authors:  Thomas J Miner; Jinru Shia; David P Jaques; David S Klimstra; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

Authors:  John A Spertus; David J Maron; David J Cohen; Paul Kolm; Pam Hartigan; William S Weintraub; Daniel S Berman; Koon K Teo; Leslee J Shaw; Steven P Sedlis; Merril Knudtson; Mihaela Aslan; Marcin Dada; William E Boden; G B John Mancini
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-09

6.  Type D personality and patient-perceived health in nonsignificant coronary artery disease: the TWeesteden mIld STenosis (TWIST) study.

Authors:  Paula M C Mommersteeg; Irene Pot; Wilbert Aarnoudse; Johan Denollet; Jos W Widdershoven
Journal:  Qual Life Res       Date:  2012-12-21       Impact factor: 4.147

7.  Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population.

Authors:  Floortje Mols; Aline J Pelle; Nina Kupper
Journal:  Qual Life Res       Date:  2009-02-26       Impact factor: 4.147

8.  Factors associated with racial differences in myocardial infarction outcomes.

Authors:  John A Spertus; Philip G Jones; Frederick A Masoudi; John S Rumsfeld; Harlan M Krumholz
Journal:  Ann Intern Med       Date:  2009-03-03       Impact factor: 25.391

9.  Validity, reliability, and responsiveness of the Kansas City Cardiomyopathy Questionnaire in anemic heart failure patients.

Authors:  John A Spertus; Philip G Jones; John Kim; Denise Globe
Journal:  Qual Life Res       Date:  2007-12-29       Impact factor: 4.147

10.  One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors.

Authors:  Thomas M Maddox; Kimberly J Reid; John S Rumsfeld; John A Spertus
Journal:  BMC Cardiovasc Disord       Date:  2007-09-12       Impact factor: 2.298
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.